Fig. 1From: Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancerThe workflow of this study. Integrating muti-omics analysis and machine learning, an epithelial cell marker gene prognostic signature (ECMGPS) was developed and validated from epithelial cell marker genes (ECMGs) to predict prognosis and treatment responseBack to article page